We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4578:TSEOtsuka Holdings Co., Ltd. Analysis

Data as of 2026-06-20 - not real-time

¥10,515.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Otsuka Holdings is trading at ¥10,515, notably below its 20‑day SMA of ¥10,815 and 50‑day SMA of ¥10,922, indicating short‑term weakness. The MACD shows a bearish divergence and the RSI sits at 44, suggesting limited upside momentum, while the stock’s beta is virtually zero, making market‑wide swings almost irrelevant. Fundamentally, the company posts solid 8.2% revenue growth, a 71.5% gross margin, and robust operating cash flow, supporting a sustainable dividend yield of 1.35% with a low 20% payout ratio. However, the DCF fair value of ¥7,423 is well under the current price, and the market cap reflects a premium that may be hard to justify, even though the PE of 15.4 is below the industry average of 24.1. Extreme greed sentiment (91.46) and a 30% 30‑day volatility add a cautionary note.
Given the stable dividend, strong cash generation, and diversified product portfolio, the stock offers defensive qualities, but the technical picture is neutral to bearish and valuation appears stretched. Investors should weigh the modest upside to analyst targets (≈¥12,700) against the risk of further downside toward the ¥10,120 support level.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD histogram
  • Support level near ¥10,120

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Consistent 8% revenue growth
  • Strong cash flow and low dividend payout
  • Target median price of ¥12,700 suggests upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable dividend yield with sustainable payout
  • Robust operating cash flow and high margins
  • Defensive beta near zero and diversified business lines

Key Metrics & Analysis

Financial Health

Revenue Growth8.20%
Profit Margin14.96%
P/E Ratio15.4
ROE12.94%
ROA7.51%
Debt/Equity6.13
P/B Ratio1.8
Op. Cash Flow¥407.0B
Free Cash Flow¥191.0B
Industry P/E24.1

Technical Analysis

TrendNeutral
RSI44.3
Support¥10,120.00
Resistance¥11,760.00
MA 20¥10,815.25
MA 50¥10,922.10
MA 200¥9,578.38
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair Value¥7,422.75
Target Price¥12,900.00
Upside/Downside22.68%
GradeOvervalued
TypeValue
Dividend Yield1.35%

Risk Assessment

Beta0.01
Volatility30.02%
Sector RiskLow
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.